We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX crawls up just 0.17pc with 7 sectors lower Healthcare sharply lower as Trump threatens tariffs...
Read ArticleThe S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on...
Read ArticleASX rises 0.22pc after flat day of trade Earnings reports from big cap companies weighed heavy Gain...
Read ArticleThe S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining mome...
Read ArticleThe ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6...
Read ArticleASX lifts 0.33pc on healthcare sector strength CSL adds 2.4pc as UBS marks ASX healthcare sector as...
Read ArticleThe S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD dow...
Read ArticleThe Western Australian Government is investing $3.3 million in specialised workforce training delive...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Mo...
Read ArticleASX drops below 8000 as tariffs send shockwaves Goodman, CBA and tech stocks take a beating Bitcoin...
Read ArticleThe S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Mo...
Read ArticleHighlights MDGH gains FDA approval for moxidectin to treat river blindness. Ghana becomes t...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Hea...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleIn this interview Dale Gillham and small cap company director Rod North discuss what to look for in...
Read ArticleAmplia CEO Dr Chris Burns and long-time scientific collaborator Professor Andrew Wilks have been aw...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleBirth rates decline as people choose careers and pets Global pet industry is benefitting from this,...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleThe S&P/ASX 200 Information Technology sector rose ~8% in August, despite a volatile month for...
Read ArticleS&P/ASX 200 recovers from heavy volatility early in the month to finish up 0.47% in August S&am...
Read ArticleTHC gummies are becoming popular for their convenience and effects Bioxyne has produced Australia’s...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleS&P/ASX 200 had its best month of the year in July finishing up 4% to record high S&P Dow J...
Read ArticleASX smacked after Wall Street sell-off sparked a red day around the world. ALL sectors lower on Fr...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleASX 200 ends 0.5pc lower after a difficult start to the week Energy Sector the worst of some poor...
Read ArticleMaterials, Energy and Infotech dominate a sluggish day on Wednesday Booktopia collapses with a grim...
Read ArticleIsland Pharmaceuticals inks deal to develop a treatment for potentially deadly viruses like Ebola A...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleS&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companie...
Read ArticleChoppy day leaves the ASX 200 benchmark below zero, down -0.2pc Energy surges on news of a coal fir...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleTwo independent appraisals value land and building owned by Melodiol’s Canadian subsidiary Mernova...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleMernova finalises additional product development activities across edibles, vapes and dabbers Agre...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX losses accelerate after sluggish retail sector updates Baby Bunting, Temple & Webster, JB...
Read ArticleMelodiol’s Canadian subsidiary Mernova continues to make strong progress Mernova launching addition...
Read ArticleNeuren Pharma’s Q1 DAYBUE sales disappoint 4DMedical’s CT LVAS technology gets reimbursement in US...
Read ArticleASX to dip slightly at the open after a modest run on Wall Street Shopify, Airbnb and Uber took...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleMelodiol Global Health Q1 FY24 unaudited revenue of $4.4m marks a 91% increase on pcp Company remai...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleWhere are we in terms of US legalisation of cannabis? What about the current legal landscape for ca...
Read ArticleUS Majority Leader Chuck Schumer is urging people to endorse SAFER Banking Act by signing petition...
Read ArticleSpecial Report: Melodiol Global’s subsidiary Mernova continues to gain traction in Canada as the com...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleThe ASX 200 erases early morning’s losses, rallying to close the day +0.3% higher. This comes as th...
Read ArticleMelodiol Global Health reports total unaudited revenue of $3.1 million in first two months of FY24...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleHub will focus on supporting global use of new treatments that effectively treated drug-resistant TB...
Read ArticleAUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures CANBERRA, Australia, March 25,...
Read ArticleS&P/ASX 200 rose 0.8% in February with Large Cap S&P/ASX 50 underperforming Midcap and Smal...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleRecce Pharmaceuticals (ASX:RCE) highlights ongoing initiatives within its Anti-Infective Research (A...
Read ArticleASX200 drops about 0.7pc on Wednesday Consumer Staples craters, as WOW CEO departs Small Caps led...
Read ArticleLocal markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200...
Read ArticleMelodiol subsidiary Mernova Medicinal continues to grow as a dominant player in lucrative Canadia...
Read ArticleASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small...
Read ArticleMelodiol Global Health says 2023 been a milestone year with strong growth across portfolio Melod...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleMelodiol subsidiary Health House International Australia delivers ~$1 million in revenue for Octobe...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and...
Read ArticleMernova Medicinal has achieved its highest ever monthly revenue of nearly $900k in October Company...
Read ArticleThe S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% f...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and...
Read ArticleBenchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW...
Read ArticleCreso Pharma has changed its name to Melodiol Global Health (ASX:MEI) The cannabis-focused health...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleOn Monday, the Australian stock market experienced a decline as investors sought refuge in bonds and...
Read ArticleGlobal Health announces deal with Fujitsu Australia Althea raises $5.32m in sale and leaseback deal...
Read ArticleOil prices remained stable as Israel had not yet initiated its expected ground offensive in Gaza, wh...
Read Article16 Oct 2023 - A snapshot of the stocks on the move, featuring Tamboran Resources (ASX:TBN), Melodiol...
Read ArticleTamboran Resources (ASX:TBN) announced that an operational update, in which the A3H well was drill...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleMelodiol Global Health (ASX:ME1) has announced that its wholly-owned psychedelics subsidiary...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleRecord sales drives Mernova to deliver third consecutive quarter of revenue growth Sales up 20% on...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleMolodiol business Mernova achieves record sales for Q3 2023 Highest-ever weekly sales in Nova Scoti...
Read ArticleWASHINGTON, Sept. 20, 2023 /PRNewswire/ -- Seventeen patient advocacy organizations from North an...
Read ArticleInterim results of operational research in LIFT-TB countries support decision to roll out improved t...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleMernova secures first cannabis purchase order from Alberta Q3 revenues already breaking records wit...
Read ArticleASX 200 find 0.5% to start the week, LTR looks ready to sell Energy stocks and miners offset IT a...
Read ArticleStockhead’s Top 10 at 11-ish, published once I’ve consumed enough coffee each trading day, highlight...
Read ArticleMelodial Global Health welcomes moves to reschedule marijuana to a lower risk category in US Analy...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleMelodial’s subsidiary Mernova looks to achieve significant quarter-on-quarter growth in Q3 Mernova...
Read Article1st Group jumps 22pc after purchase order for its virtual healthcare system Austco Healthcare wins...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe benchmark has sagged to -0.24% to close out the week with a world-weary sigh. Falling crude pr...
Read ArticleFormerly Creso Pharma, Melodiol Global Health has a new name and a fresh drive to supply best-in-cla...
Read ArticleA late surge from InfoTech pushed the benchmark to close at +0.07% InfoTech out front on +1.75%, ah...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleMelodiol Global Health have announced a non-binding Letter of Intent (LOI) to divest two of its busi...
Read ArticleThe ASX 200 put on a much better show today, with a +0.46% gain at closing time Sectors wise, Mater...
Read ArticleThe ASX 200 closed -0.10% in the red today, after feeling flat all day Sectors wise, Energy stocks...
Read ArticleMelodiol Global Health’s wholly-owned Australian Subsidiary Health House (HHI) has demonstrated it’s...
Read ArticleLawyers for descendants of the late Peter Wright were first on the stand today, taking on Gina Rineh...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleWhat a time to be alive. As the clock struck midnight to herald the start of the 23/24 financial yea...
Read ArticleAfter a strong start, the ASX levelled out as the market digested news there will be a new RBA Gover...
Read ArticleStockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have sl...
Read ArticleThe ASX 200 finishes up 1.56% The ASX XEC rises 1.52% All 11 sectors were higher lead by Real Est...
Read ArticleMelodial’s targeted M&A strategy is starting to pay off as its subsidiaries Heart Health Interna...
Read ArticleAs demand grows for its range of recreational cannabis products, ME1 has recorded strong sales figur...
Read ArticleHealth House Australia and UK operating units have become the second and third Melodiol Global Healt...
Read ArticleAn already buoyant ASX boosted past +1.1% on happy CPI data for May. Consumer Discretionary just pi...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleASX waddled to a -0.3% close, like a toddler with a turd in its trousers. Even the goldies retreate...
Read ArticleTelehealth specialist Global Health signs partnership deal with Woolworths subsidiary The deal will...
Read ArticleSaturday March 11 was a typical balmy autumnal afternoon in Melbourne, but Neuren (ASX:NEU) chief Jo...
Read ArticleThe ASX 200 was up 0.39% and ASX XEC slips 0.42% 10 out of 11 sectors were higher lead by Communica...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleMarket goes out too hard, too early and beds down for a lengthy afternoon snooze Tempus Resources s...
Read ArticleThe George Institute for Global Health has announced an agreement with the global investment...
Read ArticleASX 200 down 0.75%, dropping for the third straight day Small cap index falls 0.0.56% and 7 out 11...
Read ArticleASX 200 down 0.55% on lower than normal volume Small cap index falls 0.96% and 10 out 11 sectors...
Read ArticleShareCafeSlowing Economic Growth and Three Sectors Set to Benefit What a year 2022 has been. From sk...
Read ArticleASX 200 down -0.4% Small cap index loses -1.7% Way2VAT: killing it in the VAT space The small cap...
Read ArticleThe University of New South Wales announced 8 winners in the inaugural UNSW Founders Awards this wee...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleASX200 weakens in arvo trade ASX small caps index sheds 0.3% Victory Goldfields is really, really w...
Read ArticleThe University of NSW – the place where Atlassian’s Scott Farquhar and Mike Cannon-Brookes met – has...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleCreso Pharma (CPH) is looking to change its name to Melodiol Global Health to reflect its growth str...
Read ArticleASX cannabis shares have leapt back onto investor radars and are likely to grab more media headline...
Read ArticleA potential takeover of Ramsay Healthcare’s (RHC) 50:50 subsidiary, Ramsay Sime Darby Health Care, w...
Read ArticleIn times of great uncertainty the Australian healthcare sector can offer investors plenty of choice,...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleGlobal Health (GLH) secures a contract with the Yarram District Health Service to provide various s...
Read ArticleAnsell announces net zero commitment by 2040 Emyria extends its library of novel MDMA-like compound...
Read ArticleMoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleHighlights Global Health has inked two key contracts with Homeless Healthcare and Peninsula Heal...
Read ArticleShareCafeAustralia’s Impact on the U.S. Infant Milk Powder Crisis The share prices in both Bubs Aust...
Read ArticleGlobal Health (GLH) secures three new contracts with Arcadia Healthcare, Matilda Nepean Private Hos...
Read ArticleActor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Fran...
Read ArticleThe interest rate rise came and the markets fell, then turned a corner. The question now is — will t...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleOpyl’s contracts with two new clinical trial customers have validated the company’s pivot to focus o...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleThe healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two milli...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleExchange Traded Funds (ETFs) on the ASX have grown to a $126.9 billion industry. Here’s a guide on t...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleHighlights Telehealth companies allow patients to connect with their doctors and medical practio...
Read ArticleMany sectors of society might have come to a complete halt during COVID-19 if it was not for innovat...
Read ArticleDimerix’s lead drug candidate DMX-200 has been given regulatory green light for approval for a Phase...
Read ArticleShares in Dimerix Ltd (ASX: DXB) are soaring today, shooting up 9% in early trade. At the time of w...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read Article23 Aug 2021 - Global Health Care giant Sonic Healthcare (ASX:SHL), delivered significant revenue and...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleThe ASX ended the week on a high note, finishing up 0.13 per cent with most sectors in positive terr...
Read ArticleThe ASX had a positive trading day finishing nearly 0.5 per cent up with almost all sectors in posit...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleBiotech Global Health (ASX:GLH) topped this week’s Running Hot list, in the wake of more steady gain...
Read ArticleLast year's pandemic put the focus firmly on telehealth services providers, but share prices have de...
Read ArticleIf you thought the COVID-19 telehealth boom was big, you ain’t seen nothing yet. Telehealth adoption...
Read ArticleSummary With the current emergency, it is anticipated that telehealth or telemedicine could be t...
Read ArticleStockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical ga...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleSource: ShutterstockProfessional ,Shutterstock Summary 88 Energy has been catching attention si...
Read ArticleThe Dimerix Ltd (ASX: DXB) share price is rising today after the biopharmaceutical company announce...
Read ArticleSummary Amid growing adoption of digital platforms, Global Health registered a robust half-year...
Read ArticleSummary Global Health Ltd (ASX:GLH) said Lifecard Patient Portal is seeing high demand as health...
Read ArticleThe Global Health Limited (ASX: GLH) share price is lifting higher today after the company announce...
Read ArticleThe Dimerix Ltd (ASX: DXB) share price lifted higher today after the company announced the start of...
Read ArticleSummary eSense is working towards developing a superior organic sanitiser providing extra protec...
Read ArticleSummary As of 18 November 2020, Asia has 9.8 million ‘reported’ cases and 161,000 deaths. Count...
Read ArticleGlobal Health Limited (ASX: GLH) shares rocketed up in early trade today after the announcement of...
Read ArticleThe Global Health Limited (ASX: GLH) share price is on the rise today after the company released a...
Read ArticleThe 11 startups the UNSW Founders invested in as part of its 2020 10x accelerator program make their...
Read ArticleThe Global Health Limited (ASX: GLH) share price has rocketed higher following the release of a tra...
Read ArticleGlobal Health Limited (ASX: GLH) has been developing software for the healthcare industry for more...
Read ArticleThe share price of Australian healthcare software provider Global Health Ltd [ASX:GLH] has rocketed...
Read ArticleHealth software stock Global Health (ASX:GLH) has joined the club of ASX asthma stocks. ... Read Mor...
Read ArticleMental health stocks set to benefit from increased mental health awareness This week’s budget inclu...
Read ArticleAs the COVID-19 pandemic continues, whether the economy will ever be the same again remains is still...
Read ArticleASX telehealth stocks have had a solid six months, gaining 25 per cent, but there are warnings more...
Read ArticleThe Victorian government today announced the eagerly anticipated roadmap out of COVID-19 lockdown. I...
Read ArticleTelehealth use has only continued to increase as COVID-19 wore on throughout May and June. Both list...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, July 29. Data is taken after the mark...
Read ArticleA quick wrap of the ASX’s key winners and losers on Tuesday, July 28. Data is taken after the market...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleA quick wrap of the ASX’s key winners and losers on Friday, July 17. Data is taken after the market...
Read ArticleSummary While the benchmark index ended almost flat, two healthcare small cap stocks ended substa...
Read ArticleA quick wrap of the ASX’s key winners and losers on Tuesday, July 7. Data is taken after the market...
Read ArticleSummary While the benchmark index ended almost flat, two healthcare small cap stocks ended substa...
Read ArticleGlobal Health (ASX:GLH) continues to win new business in Victoria, with the state again re-entering...
Read ArticleFresh off its first sale in the US and positive results from a John Hopkins School of Medicine study...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleA quick wrap of the key winners and losers on Friday, June 26. Data is taken after the market closes...
Read ArticleLast week in our discussion with Bourse Communication founder and Managing Director Rod North, we ex...
Read ArticleIn our latest Finfeed podcast, Mathew Cherian, CEO at Global Health Limited (ASX: GLH) speaks with u...
Read ArticleAlmost all of the ASX’s health small caps have visions as ambitious as the Australian and state gove...
Read ArticleA visit to a new GP always involves a form on a clipboard. You fill in, with a varying degree of hon...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleLuck’s a fortune, eh? Atomo Diagnostics’ (ASX:AT1) ASX listing had been in the offing for months, ba...
Read ArticleMedtech Atomo Diagnostics had an unusual start to life as a listed company today, holding a virtua...
Read ArticleRapid blood test startup Atomo Diagnostics is playing its part in the fight against coronavirus, si...
Read ArticleMelbourne-based Global Health (ASX: GLH) was already on a roll with strong revenue growth before the...
Read ArticleThe George Institute for Global Health has announced three Australian investors have committ...
Read ArticleRamifications from the spread of the coronavirus continue to cut deep. The World Health Organization...
Read ArticleWith triple the number of sepsis cases in Australia, small cap biotech company Cynata Therapeutics (...
Read ArticleAsia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom...
Read ArticleHealth care is a huge part of the global economy and accounts for one of the fastest growing sectors...
Read ArticleIn Australia, there are plenty of high-quality health care companies, most of which have delivered e...
Read ArticleIntroduction S&P/ASX 200 Index recently made its 52-week high level of $6875.50 on July 30, 2019...
Read ArticleAustralian Health Care is a dynamic sector with a potential to generate significant profits in the l...
Read ArticleThe Spark Festival, Australia’s largest event for startups, innovators and entrepreneurs, kicks of...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleOn 1 October 2005, I was only 20 metres away from a large bomb that went off in the heart of Kuta. T...
Read ArticleDigital healthcare service has evolved as one of the fastest-growing industries in the modern era. I...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
